15 мин.
Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle MedEdTalks - Neurology
-
- Медицина
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton’s tyrosine kinase (BTK) inhibitors.
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton’s tyrosine kinase (BTK) inhibitors.
15 мин.